The rule of five should not impede anti-parasitic drug development

James H. McKerrow1, Christopher A. Lipinski2
1Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, United States
2Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, United States

Tài liệu tham khảo

Lipinski, 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev., 23, 3, 10.1016/S0169-409X(96)00423-1 Mugumbate, 2015, The relationship between target-class and the physicochemical properties of antibacterial drugs, Bioorg. Med. Chem., 23, 5218, 10.1016/j.bmc.2015.04.063 Pawlowski, 2016, Evolving medicinal chemistry strategies in antibiotic discovery, Curr. Opin. Biotechnol., 42, 108, 10.1016/j.copbio.2016.04.006 Payne, 2007, Drugs for bad bugs: confronting the challenges of antibacterial discovery, Nat. Rev. Drug Discov., 6, 29, 10.1038/nrd2201